$Illumina(ILMN.US) | Piper Sandler ๐ฆ๐๐ข๐ง๐ญ๐๐ข๐ง๐ฌ ๐๐ฏ๐๐ซ๐ฐ๐๐ข๐ ๐ก๐ญ on ๐๐ฅ๐ฅ๐ฎ๐ฆ๐ข๐ง๐, ๐ซ๐๐ข๐ฌ๐๐ฌ ๐๐ ๐ญ๐จ $๐๐๐ ๐๐ซ๐จ๐ฆ $๐๐๐
Analyst sees Illumina decoupling its growth from the volatile academic research market by shifting its revenue mix toward clinical consumables.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments